Diabetes mellitus is a common effect of uncontrolled high blood sugar and it is associated with long-term damage, dysfunction, and failure of various organs. In the adult population, the global prevalence of diabetes has nearly doubled since 1980. Without effective prevention and management programs, the continuing significant rise in diabetes will have grave consequences on the health and lifespan of the world population, and also on the world economy. Supplements can be used to correct nutritional deficiencies or to maintain an adequate intake of certain nutrients. These are often used as treatments for diabetes, sometimes because they have lower costs, or are more accessible or “natural” compared to prescribed medications. Several vitamins, minerals, botanicals, and secondary metabolites have been reported to elicit beneficial effects in hypoglycemic actions in vivo and in vitro; however, the data remain conflicting. Many pharmaceuticals commonly used today are structurally derived from natural compounds from traditional medicinal plants. Botanicals that are most frequently used to help manage blood glucose include: bitter melon (Momordica charantia), fenugreek (Trigonella foenum graecum), gurmar (Gymnema sylvestre), ivy gourd (Coccinia indica), nopal (Opuntia spp.), ginseng, Russian tarragon (Artemisia dracunculus), cinnamon (Cinnamomum cassia), psyllium (Plantago ovata), and garlic (Allium sativum). In majority of the herbal products and secondary metabolites used in treating diabetes, the mechanisms of action involve regulation of insulin signaling pathways, translocation of GLUT-4 receptor and/or activation the PPARγ. Several flavonoids inhibit glucose absorption by inhibiting intestinal α-amylase and α-glucosidase. In-depth studies to validate the efficacies and safeties of extracts of these traditional medicinal plants are needed, and large, well designed, clinical studies need to be carried out before the use of such preparations can be recommended for treatment and/or prevention of diabetes. The main focus of this review is to describe what we know to date of the active compounds in these, along with their glucose-lowering mechanisms, which are either through insulin-mimicking activity or enhanced glucose uptake.

No abstract

Propolis is a lipophilic sticky substance collected by bees that has been used by humans for centuries. Owing to its healing, antioxidant, and other medicinal properties, its chemical composition has been widely studied. Most pharmacological properties of propolis have been attributed to its phenols and terpenes, mainly flavonoids, phenolic acids, and their derivatives. More than 500 components of propolis were known from different parts of the world until 2012. In this article, 305 new constituents of propolis described between 2013 and 2018 are being reviewed, with 19 additional compounds that were discovered between 2011 and 2012, and were excluded from a similar previous review article. Altogether more than 850 compounds were isolated from propolis until 2018.

An extremely halophilic haloarchaeon Sech7a, isolated from a solar saltern, was found to excrete halocin, a bacteriocin like substance. Optimal antimicrobial activity was obtained at 45 degrees C using 0.5% (w/v) glycerol and 0.5% (w/v) yeast extract as nutrients in SW media containing 3.4 M NaCl with pH value 7.5. Halocin Sech7a is a 10.7-kDa polypeptide, which is stable in a wide range of pH and is thermolabile at temperatures above 80 degrees C. As many other halophilic proteins, halocin Sech7a loses part of its activity upon exposure to low salt conditions, yet its activity can be restored after dialysis against initial saline conditions. Microscopic inspection revealed swelling and lysis of sensitive cells upon exposure to halocin Sech7a. These results indicate that haloarchaeon Sech7a excretes a novel bacteriocin.